These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35196927)

  • 21. Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database.
    Exuzides A; Wu N; Sheinson D; Flores Avile C; Costantino C; Sidiropoulos P
    J Med Econ; 2021; 24(1):581-588. PubMed ID: 33879033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.
    Mirmosayyeb O; Ghaffary EM; Vaheb S; Pourkazemi R; Shaygannejad V
    Rev Neurol (Paris); 2023 Apr; 179(4):265-281. PubMed ID: 36658048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.
    Tomczak A; Han MH
    Mult Scler Relat Disord; 2020 Oct; 45():102347. PubMed ID: 32645636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
    Rojas JI; Alonso Serena M; Garcea O; Patrucco L; Carrá A; Correale J; Vrech C; Pappolla A; Miguez J; Doldan ML; Silveira F; Alonso R; Cohen L; Pita C; Silva BA; Fiol M; Gaitán MI; Marrodan M; Negrotto L; Ysrraelit MC; Deri N; Luetic G; Caride A; Carnero Contentti E; Lopez PA; Pettinicchi JP; Curbelo C; Martinez AD; Steinberg JD; Balbuena ME; Tkachuk V; Burgos M; Knorre E; Leguizamon F; Piedrabuena R; Liwacki SDV; Barboza AG; Nofal P; Volman G; Alvez Pinheiro A; Hryb J; Tavolini D; Blaya PA; Silva E; Blanche J; Tizio S; Caceres F; Saladino ML; Zanga G; Fracaro ME; Sgrilli G; Pagani Cassara F; Vazquez G; Sinay V; Menichini ML; Lazaro L; Cabrera LM; Bestoso S; Divi P; Jacobo M; Kohler E; Kohler M; Giunta D; Mainella C; Manzi R; Parada Marcilla M; Viglione JP; Martos I; Reich E; Jose G; Cristiano E; Fernández Liguori N;
    Neurol Sci; 2020 Jun; 41(6):1513-1519. PubMed ID: 31960250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
    Maillart E; Papeix C; Lubetzki C; Roux T; Pourcher V; Louapre C
    Mult Scler Relat Disord; 2020 Nov; 46():102482. PubMed ID: 32916509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea.
    Kim JE; Park SH; Han K; Kim HJ; Shin DW; Kim SM
    Mult Scler; 2020 Dec; 26(14):1837-1844. PubMed ID: 31749401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies.
    Kataria S; Tandon M; Melnic V; Sriwastava S
    eNeurologicalSci; 2020 Dec; 21():100287. PubMed ID: 33163634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases.
    Wang M; Dehlinger A; Zapata CF; Golan M; Gallaccio G; Sander LE; Schlickeiser S; Kunkel D; Schmitz-Hübsch T; Sawitzki B; Karni A; Braun J; Loyal L; Thiel A; Bellmann-Strobl J; Paul F; Meyer-Arndt L; Böttcher C
    Nat Commun; 2023 Nov; 14(1):7728. PubMed ID: 38007484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society.
    Vukusic S; Marignier R; Ciron J; Bourre B; Cohen M; Deschamps R; Guillaume M; Kremer L; Pique J; Carra-Dalliere C; Michel L; Leray E; Guennoc AM; Laplaud D; Androdias G; Bensa C; Bigaut K; Biotti D; Branger P; Casez O; Daval E; Donze C; Dubessy AL; Dulau C; Durand-Dubief F; Hebant B; Kwiatkowski A; Lannoy J; Maarouf A; Manchon E; Mathey G; Moisset X; Montcuquet A; Roux T; Maillart E; Lebrun-Frenay C
    Mult Scler; 2023 Jan; 29(1):37-51. PubMed ID: 36345839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder.
    Exuzides A; Sheinson D; Sidiropoulos P; Magrini F; Gholizadeh S; Surinach A; Cook L; Meyer CS; Yeaman M
    J Neurol Sci; 2021 Aug; 427():117530. PubMed ID: 34111762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saudi consensus recommendations on the management of multiple sclerosis: MS management in children and adolescents.
    Bunyan RF; AlAbdulSalam AM; Albarakati RG; Al Harbi AA; Alissa DA; Al-Jedai AH; AlKhawajah NM; Al Malik YM; Almejally MA; Al-Mudaiheem HY; AlNajashi HA; AlShehri AA; Althubaiti IA; AlYafeai RH; Babakkor MA; Cupler EJ; Ka MH; Saeedi JA; Shosha E; Al Jumah MA
    Mult Scler Relat Disord; 2022 Oct; 66():104061. PubMed ID: 35908447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
    Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
    CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil.
    Lana-Peixoto MA; Talim NC; Pedrosa D; Macedo JM; Santiago-Amaral J
    Mult Scler Relat Disord; 2021 May; 50():102807. PubMed ID: 33609926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
    Fernández VC; Alonso N; Melamud L; Villa AM
    Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19.
    Fragoso YD; Gomes S; Gonçalves MVM; Mendes Junior E; Oliveira BES; Rocha CF; Santos GACD; Tauil CB; Araujo RV; Peron JPS
    Mult Scler Relat Disord; 2022 Jan; 57():103321. PubMed ID: 35158439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.
    de Ruijter NS; Kramer G; Gons RAR; Hengstman GJD
    Mult Scler Relat Disord; 2020 Nov; 46():102474. PubMed ID: 32892062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
    Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
    Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis.
    Barzegar M; Allahdadian S; Mirmosayyeb O; Azarbayejani R; Badihian S; Nehzat N; Daryanavardi S; Barzegar S; Shaygannejad V
    Psychol Health Med; 2022 Jul; 27(6):1234-1244. PubMed ID: 33300373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
    Czarnowska A; Brola W; Zajkowska O; Rusek S; Adamczyk-Sowa M; Kubicka-Bączyk K; Kalinowska-Łyszczarz A; Kania K; Słowik A; Wnuk M; Marona M; Podlecka-Piętowska A; Nojszewska M; Zakrzewska-Pniewska B; Jasińska E; Gołuch K; Lech B; Noga M; Perenc A; Popiel M; Lasek-Bal A; Puz P; Maciejowska K; Kucharska-Lipowska M; Lipowski M; Kapica-Topczewska K; Chorąży M; Tarasiuk J; Kochanowicz J; Kulikowska J; Wawrzyniak S; Niezgodzińska-Maciejek A; Pokryszko-Dragan A; Gruszka E; Budrewicz S; Białek M; Kurkowska-Jastrzębska I; Kurowska K; Stępień A; Włodek A; Ptasznik V; Pawełczyk M; Sobolewski P; Lejmel H; Strzalińska K; Maciejowski M; Tutaj A; Zwiernik J; Litwin A; Lewańczyk B; Paprocka I; Zwiernik B; Pawlos A; Borysowicz A; Narożnik A; Michałowska A; Nosek K; Fudala M; Milewska-Jędrzejczak M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(2):212-222. PubMed ID: 33856686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
    Sadeghpour N; Mirmosayyeb O; Bjørklund G; Shaygannejad V
    J Mol Neurosci; 2020 Nov; 70(11):1829-1835. PubMed ID: 32740781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.